Microsoft word - publications_stettler.docx

1. Zueger T, Kirchner P, Herren C, Fischli S, Zwahlen M, Christ E, Glucocorticoid Replacement and Mortality in Patients with J Clin Endocrin Metab. 2012 Aug 7 (Epub ahead of print) [PMID Impact factor: 5.799. max. ranking: 0.913 in Endocrinology & 2. Zueger T, Schuler V, Stettler C, Diem P, Christ E. Assessment of three frequently used blood glucose monitoring Swiss Med Wkly. 2012 Jul 12;142:0. doi: 10.4414/smw.2012.13631 Impact factor: 1.436. max. ranking: 0.514 in Internal Medicine 3. Billinger M, Räber L, Hitz S, Stefanini GG, Pilgrim T, Stettler C, Zanchin T, Pulver C, Pfäffli N, Eberli F, Meier B, Kalesan B, Jüni P, Long-term clinical and angiographic outcomes of diabetic patients after revascularization with early generation drug-eluting stents. Am Heart J. 2012 May;163(5):876-886.e2. [PMID:22607867] Impact factor: 3.514. max. ranking: 0.838 in Cardiac & CV Systems 4. Zueger T, Diem P, Mougiakakou S, Stettler C Influence of time point of calibration on accuracy of continuous glucose monitoring in individuals with type 1 diabetes Diabetes Technol Ther. 2012 Jul;14(7):583-8.[PMID 22512266] 5. Palmerini T, Biondi-Zoccai G, Riva DD, Stettler C, Sangiorgi D, D'Ascenzo F, Kimura T, Briguori C, Sabatè M, Kim HS, De Waha A, Kedhi E, Smits PC, Kaiser C, Sardella G, Marullo A, Kirtane AJ, Leon Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis Lancet. 2012 Apr 14;379(9824):1393-402 [PMID: 22445239] Impact factor: 25.8. max. ranking: 0.99 in Medicine, General & 6. Züger T, Allemann S, Christ ER, Stettler C Exercise-induced Growth Hormone Secretion in the Assessment of Growth Hormone Deficiency in Adult Individuals Eur J Endocrinology 2011 Nov;165(5):723-8 [PMID: 21856788] Impact factor: 3.539. max. ranking: 36/105 in Endocrinology & 7. Boss A, Kreis R, Jenni S, Ith M, Nuoffer JM, Christ E, Boesch C, Non-invasive assessment of exercise-related intramyocellular acetylcarnitine in eu- and hyperglycemia in patients with type 1 diabetes using 1H-magnetic resonance spectroscopy: A randomized Diabetes Care 2011 Jan;34(1)-220-2 [PMID: 20978101] Impact factor: 6.718. max. ranking: 6/105 in Endocrinology & 8. Egger A, Boesch C, Kreis R, Buehler T, Stettler C, Christ E The Effect of Growth Hormone Replacement Therapy on Different Fat Compartments: A Whole Body Magnetic Resonance Imaging Study Eur J Endocrinology 2011 Jan;164(1):23-9 [PMID: 20930061] Impact factor: 3.539. max. ranking: 36/105 in Endocrinology & Exercise-Induced Growth Hormone Response in Eu- and Hyperglycaemia in Patients with Type 1 Diabetes Mellitus Diabet Med 2010 Feb;27(2):230-3. [PMID: 20546269] Impact factor: 3.172. max. ranking: 0.533 in Endocrinology & 10. Jenni S, Wuuest S, Konrad D, Stettler C Response of Interleukin-6 During Euglycaemic and Hyperglycaemic Exercise in Patients with Type 1 Diabetes Mellitus Diabetes Res Clin Pract. 2010 Aug;89(2):e27-9 [PMID: 20537751] Impact factor: 1.888. max. ranking: 73/93 in Endocrinology & 11. Reubi JC, Waser B, Cescato R, Gloor B, Stettler C, Christ E. Internalized Somatostatin Receptor Subtype 2 in Neuroendocrine J Clin Endocrinol Metab. 2010 May;95(5):2343-50. [PMID: 20228164] Impact factor: 5.799. max. ranking: 0.913 in Endocrinology & 12. Trepp R, Stettler C, Diem P, Christ ER Effect of Growth Hormone (GH) on Fasting and Postprandial Experimental and Clinical Endocrinology & Diabetes, 2010 Impact factor: 1,356 . max. ranking: 0.185 in Endocrinology & 13. Allemann S, Saner C, Zwahlen M, Christ ER, Diem P, Stettler C Long-term cardiovascular and non-cardiovascular mortality in women and men with type 1 and type 2 diabetes mellitus: A 30-year Swiss Med Wkly. 2009 Oct 3;139(39-40):576-83 [PMID:198388] Impact factor: 1.436. max. ranking: 0.514 in Internal Medicine 14. Allemann S, Houriet C, Diem P, Stettler C Self-monitoring of blood glucose in non-insulin treated patients with type 2 diabetes: a systematic review and meta-analysis Curr Med Res Opin. 2009 Dec; 25(12):2903-13.[PMID: 19827909] Impact factor: 3.062. max. ranking: 0.835 in Medicine, General & 15. Thom S, Stettler C, Stanton A, Witt N, Tapp R, Chaturvedi N, Allemann S, Mayet J, Sever P, Poulter N, O'Brien E, Hughes A Differential effects of anti-hypertensive treatment on the retinal microcirculation; an Anglo-Scandinavian Cardiac Outcomes Trial Hypertension, 2009 Aug;54(2):405-8 [PMID: 19528363] Impact factor: 7.194. max. ranking: 0.961 in Peripheral Vascular 16. Stettler C, Witt N, Tapp R, Stanton A, Thom S, Allemann S, Tillin T, Serum Amyloid A, C-reactive Protein and Retinal Microvascular Changes in Hypertensive Diabetic and Non-diabetic Individuals: An Diabetes Care, 2009 Jun;32(6):1098-100 [PMID: 19244088] Impact factor: 7.912. max. ranking: 0.946 in Endocrinology & 17. Stettler C, Witt N, Tapp R, Stanton A, Thom S, Allemann S, Tillin T, Retinal microvascular changes and risk of coronary heart disease in hypertensive diabetic and non-diabetic individuals: an ASCOT Impact factor: 5.247. max. ranking: 0.88 in Endocrinology & 18. Stettler C, Allemann S, Wandel S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, Suarez de Lezo J, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, De Carlo M, Erglis A, Chechi T, Ortolani P, Schalij MJ, Diem P, Meier B, Windecker S, Jüni P. Drug-Eluting versus Bare-Metal Stents in Diabetic Patients: BMJ 2008 Aug 29;337:a1331. doi: 10.1136/bmj.a1331. [PMID: Impact factor: 9.245. max. ranking: 0.942 in Medicine, General & 19. Jenni S, Oetliker C, Allemann S, Ith M, Tappy L, Wuerth S, Egger A, Boesch C, Schneiter P, Diem P, Christ E, Stettler C Fuel Metabolism During Exercise in Eu- and Hyperglycaemia in Subjects with Type 1 Diabetes Mellitus - a Prospective Single-Blinded Diabetologia. 2008 Aug;51(8):1457-65. [PMID: 18512043] Impact factor: 5.247. max. ranking: 0.88 in Endocrinology & 20. Stettler C, Stahl M, Allemann S, Diem P, Schmidlin K, Zwahlen M, Association of 1,5-Anhydroglucitol and 2-Hour Postprandial Blood Diabetes Care. 2008 Aug;31(8):1534-5. [PMID: 18426859] Impact factor: 7.912. max. ranking: 0.946 in Endocrinology & 21. Trepp R, Flück M, Stettler C, Boesch C, Ith M, Kreis R, Hoppeler H, Effect of GH on Human Skeletal Muscle Lipid Metabolism in GH- American Journal of Physiology - Endocrinology and Metabolism, Impact factor: 4.123. max. ranking: 0.835 in Physiology. 22. Billinger M, Beutler J, Taghetchian KR, Remondino A, Wenaweser P, Cook S, Togni M, Seiler C, Stettler C, Eberli FR, Lüscher TF, Wandel Two-year Clinical Outcome after Implantationof Sirolimus-Eluting and Paclitaxel-Eluting Stents in Diabetic Patients Eur Heart J. 2008 Mar;29(6):718-25. [PMID: 18272504] Impact factor: 7.286. max. ranking: 0.959 in Cardiac & Cardiovascular 23. Berneis K, Rizzo M, Stettler C, Chappuis B, Braun M, Diem P, Christ Comparative Effects of Rosiglitazone and Pioglitazone on Fasting and Postprandial LDL Size and Subclasses in Patients with Type-2 Expert Opinion in Pharmacotherapy, 2008;9(3):343-9. [PMID: Impact factor: 1.733. max. ranking: 0.442 in Pharmacology & 24. Fischli S, Jenni S, Allemann S, Zwahlen M, Diem P, Christ ER, Dehydroepiandrosterone-Sulfate in the Assessment of the J Clin Endocrin Metabol, 2008;93(2):539-42. [PMID: 17986637]; Impact factor: 5.799. max. ranking: 0.913 in Endocrinology & 25. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, Suarez de Lezo J, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Outcomes Associated with Drug-Eluting and Bare-Metal Stents: A Lancet 2007;370(9591):937-48. [PMID: 17869634]; Impact factor: 25.8. max. ranking: 0.99 in Medicine, General & 26. Chappuis B, Braun M, Stettler C, Allemann S, Diem P, Lumb PJ, Differential Effect of Pioglitazone and Rosiglitazone on Postprandial Glucose and Lipid Metabolism in Patients with Type 2 Diabetes Diabetes Metab Res Rev. 2007;23(5):392-9.; [PMID: 17211855]; Impact factor: 2.551. max. ranking: 0.565 in Endocrinology & 27. Stettler C, Bearth A, Allemann S, Zwahlen M, Zanchin L, Deplazes QTc Interval and Resting Heart Rate as Long-Term Predictors of Mortality in Type 1 and Type 2 Diabetes Mellitus: A 23-Year Follow- Diabetologia 2007;50(1):186-94. [PMID: 17096116]; Impact factor: 5.247. max. ranking: 0.88 in Endocrinology & 28. Stettler C, Suter Y, Allemann S, Zwahlen M, Christ ER, Diem P. Apolipoprotein B as a Long-Term Predictor of Mortality in Type 1 J Int Medicine 2006;260(3):272-80. [PMID: 16918825]; Impact factor: 4.73. max. ranking: 0.893 in Medicine, General & 29. Stettler C, Allemann S, Egger M, Holman R, Cull C, Jüni P, Glycemic Control and Macrovascular Disease in Types 1 and 2 Diabetes Mellitus: Meta-Analysis of Randomised Trials. Am Heart J 2006;152(1):27-38. [PMID: 16824829]; Impact factor: 3.514. max. ranking: 0.838 in Cardiac & CV Systems. 30. Allemann S, Diem P, Egger M, Christ ER, Stettler C. Fibrates in the Prevention of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus: Meta-Analysis of Randomized Controlled Curr Med Res Opin 2006;22(3):617-23. [PMID: 16574044]; Impact factor: 3.062. max. ranking: 0.835 in Medicine, General & 31. Stettler C, Jenni S, Allemann S, Steiner R, Hoppeler H, Trepp R, Exercise Capacity in Subjects with Type 1 Diabetes Mellitus in Eu- Diabetes Metab Res and Rev 2006;22(4):300-6. [PMID: 16302286]; Impact factor: 2.551. max. ranking: 0.565 in Endocrinology & 32. Stettler C, Allemann S, Diem P, Meier B, Windecker S , Egger M. Efficacy of Drug Eluting Stents in Patients with and without Diabetes Mellitus: Indirect Comparison of Randomized Controlled Trials. Heart 2006;92(5):650-7 [PMID: 16251229]; Impact factor: 3.708. max. ranking: 0.865 in Cardiac & Cardiovascular 33. Trepp R, Everts R, Stettler C, Allemann S, Fischli S, Christ ER. Assessment of Quality of Life in Patients with Uncontrolled versus Controlled Acromegaly using the Acromegaly Quality of Life Clin Endocrinol 2005;63(1):103-10. [PMID: 15963069] Impact factor: 3.358. max. ranking: 0.685 in Endocrinology & 34. Trepp R, Stettler C, Zwahlen M, Seiler R, Diem P, and Christ ER. Treatment Outcomes and Mortality of 94 Patients with Acromegaly. Acta Neurochir 2005;147(3):243-51. [PMID: 15627919]; Impact factor: 1.212. max. ranking: 0.555 in Surgery. 35. Egger M, Davey Smith G, Stettler C, Diem P. Risk of Adverse Effects of Intensified Treatment in Insulin-dependent Diabet Med 1997;14(11):919-28. [PMID: 9400915]; Impact factor: 2.484. max. ranking: 0.533 in Endocrinology & PMID denotes PubMed Unique Identifier; Impact factors and journal rankings were extracted from ISI Journal Citation Report Science Edition (available at http://wok.consortium.ch/portal.cgi/JCR) Phächromozytome und funktionelle Paragangliome Deciding among the many oral hypoglycemic agents 38. Zueger T, Buehler A, Stalder M, Walpoth N, Reubi JC, Stettler C A Rare Localization of a Neuroendocrine Tumor J Clin Endocrin Metab 2011; 96(6):1625-6 Schilddrüsenknoten – welche Abklärungsschritte sind sinnvoll? Schweiz Rundsch Med Prax. 2010;99(10):603-8 40. Sahli R, Krull I, Christ E, Waschkowski G, Stettler C Nicht verzagen – den Pathologen fragen 41. Krull I, Sahli R, Diem P, Stettler C Variability in Cross-Reactivity of Novel Insulin Analogues in Diabet Med. 2009 Oct;26(10):1075-6. [PMID: 19900243] Impact factor: 3.172. max. ranking: 0.533 in Endocrinology & 43. Stettler C, Stahl M, Allemann S, Diem P, Schmidlin K, Zwahlen M, Association of 1,5-Anhydroglucitol and 2-Hour Postprandial Blood Glucose in Type 2 Diabetic Patients: Response to Schindhelm et al. Diabetes Care. 2008 Nov;31(11):e90. [PMID: 18955717] Impact factor: 7.912. max. ranking: 0.946 in Endocrinology & Insulintherapie bei Typ-2-Diabetes –Welche Strategie ist die beste? 46. Jenni S, Gloor B, Stettler C, Christ ER. Am J Med. 2007 Oct;120(10):848-50. (PMID: 17986637) Impact factor: 4.518. max. ranking: 0.874 in Medicine, General & Rosiglitazone und kardiovaskuläres Risiko. 48. Jenni S, Seiler R, Christ ER, Stettler C. Simultaneous defect of visual fields and loss of libido--a coincidence? Schweiz Rundsch Med Prax. 2006 Dec 6;95(49):1925-30. [PMID: A rare cause of cardiogenic shock with psychotic symptoms. Dtsch Med Wochenschr. 2006;20;131(42):2333-6. [PMID: 17043983] Impact factor: 0.584. max. ranking: 0.272 in Medicine, General & HbA1c als Prädiktor für die Diabetesentwicklung. Pioglitazon in der Sekundärprävention bei Typ 2 Diabetes. Metformin bei Diabetes und Herzinsuffizienz. Vergleichbare kardiovaskuläre Wirkung der heute verfügbaren Antihypertensiva bei Individuen mit und ohne Diabetes mellitus. Orale Antikoagulation: Höhere Eigenverantwortung reduziert die Diabetesprävention durch Orlistat und Lifestyle-Veränderungen. Bedeutung der postprandialen Blutzuckerspitzen für die What you always wanted to know about HbA1c. Schweiz Med Wochenschr. 2000;130(26):993-1005. [PMID: Impact factor: 1.226. Journal ranking: 43/105 in Medicine, General & 60. Kühn F, Stettler C, Müller B, Diem P. Diabetes mellitus und seine Folgeerkrankungen Public Health, Sozial- und Präventivmedizin kompakt; M. Egger, O.

Source: http://www.artorg.unibe.ch/unibe/medizin/artorg/content/e822/e1159/e1161/e80091/e80095/e151143/Publications_Stettler_eng.pdf